Additionally, the amount of oral CTS inhaled into the systemic circulation was small (Song et al., 2007; Wang et al., 2020), so choosing a higher dose may be beneficial to compare the pharmacokinetic characteristics of CTS in normal and pulmonary fibrosis rats. Here, TTR is linked to pulmonary fibrosis.